Valley National Advisers Inc Gsk PLC Transaction History

Valley National Advisers Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$38.88 - $45.31 $1,477 - $1,721	-38 Reduced 2.72%	1,361 $60,000
Q1 2021 May 07, 2021	BUY	$34.27 - $40.01 $274 - $320	8 Added 0.58%	1,399 $50,000
Q4 2020 Feb 11, 2021	SELL	$34.07 - $39.94 $5,928 - $6,949	-174 Reduced 11.12%	1,391 $51,000
Q4 2019 Feb 13, 2020	BUY	$42.0 - $48.25 $4,536 - $5,211	108 Added 7.41%	1,565 $74,000
Q4 2018 Feb 25, 2019	BUY	$37.8 - $42.69 $7,597 - $8,580	201 Added 16.0%	1,457 $56,000
Q3 2018 Nov 08, 2018	SELL	$39.75 - $42.69 $168,858 - $181,347	-4,248 Reduced 77.18%	1,256 $50,000
Q1 2018 Apr 19, 2018	SELL	$36.18 - $40.15 $5,499 - $6,102	-152 Reduced 2.69%	5,504 $215,000
Q4 2017 Feb 13, 2018	SELL	$35.34 - $41.9 $132,383 - $156,957	-3,746 Reduced 39.84%	5,656 $201,000
Q3 2017 Nov 14, 2017	BUY	$39.44 - $41.55 $370,814 - $390,653	9,402	9,402 $382,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

Stay updated on Valley National Advisers Inc with notifications on news.